Total Payments
$38,742
2024 Payments
$4,407
Companies
27
Transactions
303
Medicare Patients
3,770
Medicare Billing
$654,535
Payment Breakdown by Category
Other$18,231 (47.1%)
Consulting$9,100 (23.5%)
Food & Beverage$5,889 (15.2%)
Travel$5,410 (14.0%)
Education$112.26 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,831 | 10 | 40.9% |
| Consulting Fee | $9,100 | 3 | 23.5% |
| Food and Beverage | $5,889 | 238 | 15.2% |
| Travel and Lodging | $5,410 | 27 | 14.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,400 | 1 | 6.2% |
| Education | $112.26 | 24 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $17,147 | 49 | $0 (2022) |
| Relypsa, Inc. | $7,792 | 28 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $4,574 | 56 | $0 (2024) |
| Retrophin, Inc. | $3,032 | 11 | $0 (2019) |
| Ultragenyx Pharmaceutical Inc. | $2,809 | 6 | $0 (2019) |
| Amgen Inc. | $743.80 | 13 | $0 (2022) |
| Vifor Pharma, Inc. | $573.00 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $571.85 | 31 | $0 (2024) |
| Travere Therapeutics, Inc. | $188.25 | 20 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $178.66 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,407 | 31 | Fresenius USA Marketing, Inc. ($4,014) |
| 2023 | $687.41 | 40 | Fresenius USA Marketing, Inc. ($182.67) |
| 2022 | $741.68 | 46 | Vifor Pharma, Inc. ($231.50) |
| 2021 | $614.40 | 37 | Vifor Pharma, Inc. ($221.13) |
| 2020 | $470.28 | 24 | Relypsa, Inc. ($192.14) |
| 2019 | $3,468 | 43 | Ultragenyx Pharmaceutical Inc. ($2,809) |
| 2018 | $15,616 | 48 | Relypsa, Inc. ($7,463) |
| 2017 | $12,736 | 34 | Otsuka America Pharmaceutical, Inc. ($12,044) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.02 | General |
| 12/04/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Cardio-renal | ||||||
| 09/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Immunology | ||||||
| 08/09/2024 | Fresenius USA Marketing, Inc. | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,400.00 | General |
| 08/09/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $525.88 | General |
| 08/09/2024 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $237.36 | General |
| 08/09/2024 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| 08/08/2024 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $706.95 | General |
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: DIABETES | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Diabetes | ||||||
| 05/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.40 | General |
| 05/02/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Hyperkalemia | ||||||
| 04/18/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $16.40 | General |
| 03/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.42 | General |
| 03/18/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Hyperkalemia | ||||||
| 03/12/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $3.74 | General |
| 02/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Nephrology | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $19.30 | General |
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 930 | 1,743 | $488,178 | $132,878 |
| 2022 | 14 | 822 | 1,633 | $528,693 | $142,925 |
| 2021 | 15 | 899 | 1,911 | $597,635 | $189,567 |
| 2020 | 20 | 1,119 | 2,156 | $619,865 | $189,164 |
Total Patients
3,770
Total Services
7,443
Medicare Billing
$654,535
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 600 | $191,753 | $42,408 | 22.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 253 | $73,708 | $23,659 | 32.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 18 | 52 | $45,800 | $14,382 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 177 | $34,560 | $11,008 | 31.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 75 | $32,874 | $10,218 | 31.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 62 | 153 | $18,666 | $5,851 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $17,946 | $5,571 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 81 | $18,306 | $4,756 | 26.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 94 | $14,733 | $4,619 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 47 | $21,025 | $4,513 | 21.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 31 | 55 | $6,896 | $2,159 | 31.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 20 | $6,528 | $2,047 | 31.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 16 | $2,857 | $897.28 | 31.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 46 | 46 | $2,222 | $695.52 | 31.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 31 | 31 | $303.80 | $96.41 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 303 | 655 | $206,266 | $43,147 | 20.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 100 | 367 | $91,225 | $29,221 | 32.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 31 | 104 | $51,964 | $16,806 | 32.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 60 | $28,871 | $9,336 | 32.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 25 | 33 | $28,931 | $9,269 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 134 | $29,932 | $8,453 | 28.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 105 | $18,164 | $5,888 | 32.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 16 | 22 | $15,999 | $5,182 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $14,692 | $4,543 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $13,990 | $3,734 | 26.7% |
About Dr. Shaun Conlon, M.D
Dr. Shaun Conlon, M.D is a Nephrology healthcare provider based in Lawrenceville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1760667034.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shaun Conlon, M.D has received a total of $38,742 in payments from pharmaceutical and medical device companies, with $4,407 received in 2024. These payments were reported across 303 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,831).
As a Medicare-enrolled provider, Conlon has provided services to 3,770 Medicare beneficiaries, totaling 7,443 services with total Medicare billing of $654,535. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Lawrenceville, GA
- Active Since 01/07/2008
- Last Updated 09/18/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1760667034
Products in Payments
- SAMSCA (Drug) $12,921
- Veltassa (Drug) $8,365
- JYNARQUE (Drug) $4,298
- (815) Thiola (Drug) $3,039
- CRYSVITA (Drug) $2,809
- Velphoro (Drug) $467.34
- LOKELMA (Drug) $320.47
- FARXIGA (Drug) $207.20
- Auryxia (Drug) $171.86
- Kerendia (Drug) $171.37
- Parsabiv (Biological) $139.00
- JARDIANCE (Drug) $125.97
- LUPKYNIS (Drug) $99.96
- Thiola (Drug) $99.20
- Rayaldee (Drug) $92.80
- INJECTAFER (Drug) $90.43
- AURYXIA (Drug) $81.19
- TARPEYO (Drug) $54.69
- Parsabiv (Drug) $54.48
- BENLYSTA (Biological) $36.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Lawrenceville
Dr. James Tumlin, M.d, M.D
Nephrology — Payments: $502,313
Nephrology $502,313
Dr. Sharad Virmani, M.d, M.D
Nephrology — Payments: $38,080
Nephrology $38,080
Aakash Amin, M.d, M.D
Nephrology — Payments: $21,082
Nephrology $21,082
Kathryn Elmore, M.d, M.D
Nephrology — Payments: $12,236
Nephrology $12,236
Mrs. Chigozie Uko, Np-C, NP-C
Nephrology — Payments: $8,790
Nephrology $8,790
Dr. Nnamdi Nwaohiri, M.d, M.D
Nephrology — Payments: $7,814
Nephrology $7,814